Read on to learn about the research around GLP-1, SGLT-2, and combination therapy use in type 1 diabetes. Dr. Paresh Dandona is a Distinguished Professor and Chief of...
Type 1 Diabetes News
Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels.
59 readers recommended
48 readers recommended
For now, another SGLT-2 inhibitor pill already approved for people with type 2 diabetes is not approved for people with type 1 diabetes in the US. The drug was recently...
64 readers recommended
What I've Learned From 70,000 Hours Wearing CGM - A Video Presentation at Thriveabetes 2019
50 readers recommended
New updates include time-in-range goals, heart health benefits of GLP-1 agonist Trulicity, and recommendation of GLP-1 agonist Victoza for children and teens with type 2...
50 readers recommended
As we demand more nutritious and sustainable food, big food companies must make adjustments to their products, practices, and marketing
57 readers recommended
A currently-recruiting trial is comparing how two types of basal insulin – Toujeo and Tresiba – impact blood sugar levels in adults, using continuous glucose monitoring
102 readers recommended
New partnerships with Tidepool Loop, plus two new models of virtual clinical care
45 readers recommended
Beginning in 2020, nation-wide Cigna (and Express Scripts) and three Minnesota insurance companies (Blue Cross and Blue Shield, Medica, and UCare) will cap total monthly...
43 readers recommended
Children, ages 4 to 17, met with Members of Congress to help them understand what it’s like to live with type 1 diabetes and why research for a cure is so important...
37 readers recommended
Xofluza was recently approved to treat the flu in higher-risk populations – people with diabetes or other chronic conditions, and people over age 65 – and to prevent...
42 readers recommended
Eli Lilly to donate 200,000 insulin pens and provide $2 million for diabetes education to 200 free clinics across the United States by 2022
53 readers recommended
Control-IQ Hybrid Closed Loop on track to launch in the US by the end of 2019 for those ages 14 and older; first system with automatic correction boluses and no...
55 readers recommended
A new paper suggests that as people with diabetes increase their time in range, healthcare costs decrease
42 readers recommended
Jamie Kurtzig, a high school student living with type 1 diabetes, just published a book of 100 poems that she has written over the last ten years
55 readers recommended
The diaTribe team was in Barcelona for the 55 th Annual Meeting of the European Association for the Study of Diabetes. Check out our biggest highlights from the...
46 readers recommended
These new rules will save both consumers and health plan providers thousands of dollars a year through pre-deductible coverage of chronic condition treatments
40 readers recommended
Data from the CDC show that 17% of people in Colorado self-report an inactive lifestyle, up to 48% of people in Puerto Rico
41 readers recommended
diaTribe Community Manager, Cherise Shockley, shares the story of her diabetes diagnosis and how that diagnosis affected her family
62 readers recommended
This study, now recruiting 350 participants, will examine the safety of the MiniMed 780G Advanced Hybrid Closed Loop System in people with type 1 diabetes (7+ Years)
43 readers recommended
The diaTribe Foundation’s sixth annual “Solvable Problems in Diabetes” in Barcelona brought together more than 140 leaders to discuss challenges and opportunities in...